SEARCH

SEARCH BY CITATION

References

  • Allen, D. L., J. J. Uyenishi, A. S. Cleary, R. S. Mehan, S. F. Lindsay, and J. M. Reed. 2010. Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298:R198R210.
  • Ayala, J. E., V. T. Samuel, G. J. Morton, S. Obici, C. M. Croniger, G. I. Shulman, et al. 2010. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis. Model. Mech. 3:525534.
  • Begue, G., A. Douillard, O. Galbes, B. Rossano, B. Vernus, R. Candau, et al. 2013. Early activation of rat skeletal muscle IL-6/STAT1/STAT3 dependent gene expression in resistance exercise linked to hypertrophy. PLoS ONE 8:e57141.
  • Benrick, A., V. Wallenius, and I. W. Asterholm. 2012. Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice. Exp. Physiol. 97:12241235.
  • Blachnio-Zabielska, A., M. Baranowski, P. Zabielski, and J. Gorski. 2010. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle. J. Cell. Physiol. 225:786791.
  • Bloemberg, D., and J. Quadrilatero. 2012. Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS ONE 7:e35273.
  • Bradley, R. L., J. Y. Jeon, F. F. Liu, and E. Maratos-Flier. 2008. Voluntary exercise improves insulin sensitivity and adipose tissue inflammation in diet-induced obese mice. Am. J. Physiol. Endocrinol. Metab. 295:E586E594.
  • Calder, P. C., N. Ahluwalia, F. Brouns, T. Buetler, K. Clement, K. Cunningham, et al. 2011. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 106(Suppl 3):S5S78.
  • Carey, A. L., G. R. Steinberg, S. L. Macaulay, W. G. Thomas, A. G. Holmes, G. Ramm, et al. 2006. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55:26882697.
  • Di Gregorio, G. B., L. Hensley, T. Lu, G. Ranganathan, and P. A. Kern. 2004. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am. J. Physiol. Endocrinol. Metab. 287:E182E187.
  • Febbraio, M. A., A. Steensberg, C. Keller, R. L. Starkie, H. B. Nielsen, P. Krustrup, et al. 2003. Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. J. Physiol. 549:607612.
  • Glund, S., A. Deshmukh, Y. C. Long, T. Moller, H. A. Koistinen, K. Caidahl, et al. 2007. Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes 56:16301637.
  • van Hall, G., A. Steensberg, M. Sacchetti, C. Fischer, C. Keller, P. Schjerling, et al. 2003. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 88:30053010.
  • Hawley, J. A., and S. J. Lessard. 2008. Exercise training-induced improvements in insulin action. Acta Physiol. 192:127135.
  • Heinrich, P. C. B. I., G. Muller-Newen, F. Schaper, and L. Graeve. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:297314.
  • Holloszy, J. O. B. F. 1976. Biochemical adaptations to endurance exercise in muscle. Annu. Rev. Physiol. 38:273291.
  • Kado, S., T. Nagase, and N. Nagata. 1999. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol. 36:6772.
  • Kanemaki, T., H. Kitade, M. Kaibori, K. Sakitani, Y. Hiramatsu, Y. Kamiyama, et al. 1998. Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology 27:12961303.
  • Kern, P. A., S. Ranganathan, C. Li, L. Wood, and G. Ranganathan. 2001. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280:E745E751.
  • Kim, T. H., S. E. Choi, E. S. Ha, J. G. Jung, S. J. Han, H. J. Kim, et al. 2013. IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetol. 50:189200.
  • Knudsen, J. G., M. Murholm, A. L. Carey, R. S. Bienso, A. L. Basse, T. L. Allen, et al. 2014. Role of IL-6 in exercise training- and cold-induced UCP1 expression in subcutaneous white adipose tissue. PLoS ONE 9:e84910.
  • Malin, S. K., R. Gerber, S. R. Chipkin, and B. Braun. 2012. Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 35:131136.
  • Martin, T. L., T. Alquier, K. Asakura, N. Furukawa, F. Preitner, and B. B. Kahn. 2006. Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J. Biol. Chem. 281:1893318941.
  • Matthews, V. B., T. L. Allen, S. Risis, M. H. Chan, D. C. Henstridge, N. Watson, et al. 2010. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetol 53:24312441.
  • McGuinness, O. P., J. E. Ayala, M. R. Laughlin, and D. H. Wasserman. 2009. NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse. Am. J. Physiol. Endocrinol. Metab. 297:E849E855.
  • Metzger, S. G. N., V. Barash, T. Peretz, O. Drize, J. Shilyansky, E. Shiloni, et al. 1997. Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels. Am. J. Physiol. 273:E262E267.
  • Nedergaard, J., V. Golozoubova, A. Matthias, A. Asadi, A. Jacobsson, and B. Cannon. 2001. UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim. Biophys. Acta 1504:82106.
  • Ostrowski, K., T. Rohde, S. Asp, P. Schjerling, and B. K. Pedersen. 1999. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J. Physiol. 515(Pt 1):287291.
  • Pedersen, B. K., and M. A. Febbraio. 2012. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8:457465.
  • Pellegrino, M. A., L. Brocca, F. S. Dioguardi, R. Bottinelli, and G. D'Antona. 2005. Effects of voluntary wheel running and amino acid supplementation on skeletal muscle of mice. Eur. J. Appl. Physiol. 93:655664.
  • Sakamoto, T., N. Takahashi, Y. Sawaragi, S. Naknukool, R. Yu, T. Goto, et al. 2013. Inflammation induced by RAW macrophages suppresses UCP1 mRNA induction via ERK activation in 10T1/2 adipocytes. Am. J. Physiol. Cell Physiol. 304:C729C738.
  • Sarvas, J. L., N. Khaper, and S. J. Lees. 2013. The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK. J. Diabetes Metab. doi:10.4172/2155-6156.S13-003.
  • Sharma, N., D. A. Sequea, C. M. Castorena, E. B. Arias, N. R. Qi, and G. D. Cartee. 2013. Heterogeneous effects of calorie restriction on in vivo glucose uptake and insulin signaling of individual rat skeletal muscles. PLoS ONE 8:e65118.
  • Sharoff, C. G., T. A. Hagobian, S. K. Malin, S. R. Chipkin, H. Yu, M. F. Hirshman, et al. 2010. Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals. Am. J. Physiol. Endocrinol. Metab. 298:E815E823.
  • Shi, H., I. Tzameli, C. Bjorbaek, and J. S. Flier. 2004. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J. Biol. Chem. 279:3473334740.
  • Shi, H., B. Cave, K. Inouye, C. Bjorbaek, and J. S. Flier. 2006. Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 55:699707.
  • Spangenburg, E. E., D. A. Brown, M. S. Johnson, and R. L. Moore. 2006. Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J. Physiol. 572:839848.
  • Starkie, R., S. R. Ostrowski, S. Jauffred, M. Febbraio, and B. K. Pedersen. 2003. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 17:884886.
  • Steensberg, A., M. A. Febbraio, T. Osada, P. Schjerling, G. van Hall, B. Saltin, et al. 2001. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J. Physiol. 537:633639.
  • Steensberg, A., C. P. Fischer, C. Keller, K. Moller, and B. K. Pedersen. 2003. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol. Endocrinol. Metab. 285:E433E437.
  • Steinberg, G. R., D. J. Dyck, J. Calles-Escandon, N. N. Tandon, J. J. Luiken, J. F. Glatz, et al. 2002. Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J. Biol. Chem. 277:88548860.
  • Thio, L. L., E. Erbayat-Altay, N. Rensing, and K. A. Yamada. 2006. Leptin contributes to slower weight gain in juvenile rodents on a ketogenic diet. Pediatr. Res. 60:413417.
  • Todd, M. K., B. B. 3rd Yaspelkis, and L. P. Turcotte. 2005. Short-term leptin treatment increases fatty acids uptake and oxidation in muscle of high fat-fed rats. Metab., Clin. Exp. 54:12181224.
  • Ueki, K., T. Kondo, and C. R. Kahn. 2004. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell. Biol. 24:54345446.
  • Viollet, B., M. Foretz, B. Guigas, S. Horman, R. Dentin, L. Bertrand, et al. 2006. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J. Physiol. 574:4153.
  • Wallenius, K., V. Wallenius, D. Sunter, S. L. Dickson, and J. O. Jansson. 2002a. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem. Biophys. Res. Commun. 293:560565.
  • Wallenius, V., K. Wallenius, B. Ahren, M. Rudling, H. Carlsten, S. L. Dickson, et al. 2002b. Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8:7579.
  • Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:17961808.
  • Wolsk, E., H. Mygind, T. S. Grondahl, B. K. Pedersen, and G. van Hall. 2011. The role of leptin in human lipid and glucose metabolism: the effects of acute recombinant human leptin infusion in young healthy males. Am. J. Clin. Nutr. 94:15331544.